Monday, August 31, 2020

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion The offer values the California-based biopharmaceutical company at $2.6 billion, including the $473 million that Nestle had already invested in Aimmune, Nestle said in a statement.

from Moneycontrol Business News https://ift.tt/2QEFiGF

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...